Guinea Worm Disease Eradication Is Within Reach

JAMA ◽  
2021 ◽  
Vol 326 (23) ◽  
pp. 2353
Author(s):  
Bridget M. Kuehn
2013 ◽  
Vol 368 (1623) ◽  
pp. 20120146 ◽  
Author(s):  
Gautam Biswas ◽  
Dieudonne P. Sankara ◽  
Junerlyn Agua-Agum ◽  
Alhousseini Maiga

Dracunculiasis, commonly known as guinea worm disease, is a nematode infection transmitted to humans exclusively via contaminated drinking water. The disease prevails in the most deprived areas of the world. No vaccine or medicine is available against the disease: eradication is being achieved by implementing preventive measures. These include behavioural change in patients and communities—such as self-reporting suspected cases to health workers or volunteers, filtering drinking water and accessing water from improved sources and preventing infected individuals from wading or swimming in drinking-water sources—supplemented by active surveillance and case containment, vector control and provision of improved water sources. Efforts to eradicate dracunculiasis began in the early 1980s. By the end of 2012, the disease had reached its lowest levels ever. This paper reviews the progress made in eradicating dracunculiasis since the eradication campaign began, the factors influencing progress and the difficulties in controlling the pathogen that requires behavioural change, especially when the threat becomes rare. The challenges of intensifying surveillance are discussed, particularly in insecure areas containing the last foci of the disease. It also summarizes the broader benefits uniquely linked to interventions against dracunculiasis.


2014 ◽  
Vol 90 (3) ◽  
pp. 393-401 ◽  
Author(s):  
Alexander H. Jones ◽  
Steven Becknell ◽  
P. Craig Withers ◽  
Ernesto Ruiz-Tiben ◽  
Donald R. Hopkins ◽  
...  

The Lancet ◽  
2019 ◽  
Vol 393 (10178) ◽  
pp. 1261 ◽  
Author(s):  
The Lancet

The Lancet ◽  
2009 ◽  
Vol 373 (9670) ◽  
pp. 1159 ◽  
Author(s):  
Wairagala Wakabi

2021 ◽  
Vol 13 (3) ◽  
pp. 215-221
Author(s):  
Teshome Gebre

Abstract There have been various infectious disease eradication programs implemented in various parts of the world with varying degrees of success since the early 1900s. Of all those programs, the one that achieved monumental success was the Smallpox Eradication Program (SEP). Most of the global health leaders and authorities that came up with the new idea of disease eradication in the 1980s tried to design and shape the new programs based on their experience in the SEP. The SEP had a very effective tool, vaccine, that did not require a cold chain system, and a relatively simple way of administration. The total cost of the eradication program was about US$300 million and the entire campaign took about 10 y. However, the Guinea worm and polio eradication programs that followed in the footsteps of SEP attained varying levels of success, consuming a huge amount of resources and taking a much longer time (>30 y each). This paper reviews the factors that played major roles in hindering the attainment of eradication goals and outlines possible recommendations for the way forward. Among other things, this paper strongly emphasizes that endemic countries should take the lead in all matters pertaining to making decisions for disease elimination and/or eradication initiatives and that ‘elimination as a public health problem’ is the preferred option rather than going for complete eradication at the expense of other health programs and thereby contributing to weakening of already fragile health systems, mainly in Africa.


2013 ◽  
pp. 41-53
Author(s):  
Samuel Makoy ◽  
Steven R. Becknell ◽  
Alexander H. Jones ◽  
Gabriel Waat ◽  
Ernesto Ruiz-tiben ◽  
...  

2013 ◽  
Vol 7 (5) ◽  
pp. e2160 ◽  
Author(s):  
Kelly Callahan ◽  
Birgit Bolton ◽  
Donald R. Hopkins ◽  
Ernesto Ruiz-Tiben ◽  
P. Craig Withers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document